Parmax Pharma Q1 Results

  • BSE: 540359
  • NSE: -
  • ISIN: INE240T01014
  • Sector: Biotechnology & Drugs
BSE
43.70.00 (0.00%)
Volume7.00
Updated: Tue 26 Nov, 2024 | 10:56:21
NSE
This stock is not traded on NSE
Today: 43.70
43.70
52-Wk: 24.18
54.00

Q1 Results Highlights

  • Total Income
    ₹7.82 Cr.
    (83.59%)
  • Operating Profit
    ₹0.12 Cr.
    (NA%)
  • Profit After Tax
    ₹0.01 Cr.
    (NA%)
  • Operating Margin
    1.50%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Parmax Pharma Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 24QoQ CompJun 23YoY Comp
Total Revenue 7.824.26-%1.40-%
Selling/ General/ Admin Expenses Total 0.750.50-%0.72-%
Depreciation/ Amortization 0.400.41-%0.42-%
Other Operating Expenses Total 0.691.30-%0.90-%
Total Operating Expense 7.705.46-%2.47-%
Operating Income 0.12-1.21-%-1.07-%
Net Income Before Taxes 0.01-1.36-%-1.18-%
Net Income 0.01-1.48-%-1.18-%
Diluted Normalized EPS 0.03-3.96-%-3.15-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts